Viscient Biosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1M

  • Investors
  • 4

Viscient Biosciences General Information

Description

Developer of a drug discovery platform designed to focus on utilizing three-dimensional tissue technology. The company's platform engages in analysis to develop drugs across a range of therapeutic areas, with an initial focus on non-alcoholic steatohepatitis, enabling medical practitioners to detect genes and pathways that drive disease progression.

Contact Information

Website
www.viscientbiosciences.com
Formerly Known As
Entelechy Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11575 Sorrento Valley Road
  • Suite 208
  • San Diego, CA 92121
  • United States
+1 (310)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 11575 Sorrento Valley Road
  • Suite 208
  • San Diego, CA 92121
  • United States
+1 (310)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viscient Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 15-Sep-2021 $1M Completed Generating Revenue
2. Early Stage VC 06-Jul-2020 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Jun-2019 Completed Generating Revenue
To view Viscient Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Viscient Biosciences Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Viscient Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023260353-A1 Tryptanthrin derivatives and uses thereof Pending 26-Apr-2022
EP-4514804-A1 Tryptanthrin derivatives and uses thereof Pending 26-Apr-2022
EP-4514804-A4 Tryptanthrin derivatives and uses thereof Pending 26-Apr-2022
US-20250171452-A1 Tryptanthrin derivatives and uses thereof Pending 26-Apr-2022
WO-2023211977-A1 Tryptanthrin derivatives and uses thereof Inactive 26-Apr-2022 C07D487/04
To view Viscient Biosciences’s complete patent history, request access »

Viscient Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viscient Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Methuselah Foundation Not-For-Profit Venture Capital
Harmonix Fund Venture Capital Minority
Methuselah Fund Venture Capital Minority
Thynk Capital Venture Capital Minority
To view Viscient Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Viscient Biosciences FAQs

  • When was Viscient Biosciences founded?

    Viscient Biosciences was founded in 2016.

  • Where is Viscient Biosciences headquartered?

    Viscient Biosciences is headquartered in San Diego, CA.

  • What is the size of Viscient Biosciences?

    Viscient Biosciences has 9 total employees.

  • What industry is Viscient Biosciences in?

    Viscient Biosciences’s primary industry is Drug Discovery.

  • Is Viscient Biosciences a private or public company?

    Viscient Biosciences is a Private company.

  • What is Viscient Biosciences’s current revenue?

    The current revenue for Viscient Biosciences is .

  • How much funding has Viscient Biosciences raised over time?

    Viscient Biosciences has raised $1.3M.

  • Who are Viscient Biosciences’s investors?

    Methuselah Foundation, Harmonix Fund, Methuselah Fund, and Thynk Capital have invested in Viscient Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process